Showing 61 - 80 results of 1,095 for search '(( significantly a decrease ) OR ( significantly ((reduced disease) OR (reported decrease)) ))~', query time: 0.53s Refine Results
  1. 61
  2. 62
  3. 63
  4. 64
  5. 65
  6. 66
  7. 67
  8. 68

    Individual survival data values. by Özgün Le Roux (18271992)

    Published 2024
    “…The incidence of myeloproliferative disease was also significantly reduced with increased p53 dosage in the <i>Kras</i><sup><i>Q61R</i></sup> background. …”
  9. 69

    Incidence, grading, and number of lung lesions. by Özgün Le Roux (18271992)

    Published 2024
    “…The incidence of myeloproliferative disease was also significantly reduced with increased p53 dosage in the <i>Kras</i><sup><i>Q61R</i></sup> background. …”
  10. 70

    DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  11. 71

    DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  12. 72

    DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  13. 73

    DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  14. 74
  15. 75
  16. 76

    Table_1_Essential tremor patients experience significant burden beyond tremor: A systematic literature review.DOCX by Margaret E. Gerbasi (13136193)

    Published 2022
    “…The reduced function and psychosocial deficits observed in patients with ET result in significant clinical and humanistic burdens, decreasing quality of life. …”
  17. 77
  18. 78
  19. 79
  20. 80